Literature DB >> 28452064

Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12.

E Audureau1,2, C Hua3, N de Prost4,5, F Hemery6, J W Decousser7, R Bosc8, R Lepeule7, O Chosidow3,9,10, E Sbidian3,9,10.   

Abstract

BACKGROUND: Necrotizing soft-tissue infections (NSTI) are rare, life-threatening conditions.
OBJECTIVES: To assess whether admitting hospital characteristics were associated with NSTI mortality.
METHODS: We studied the French nationwide hospital discharge database (retrospective national cohort). All patients admitted in the period 2007-12 with an International Classification of Diseases 10 code of necrotizing fasciitis were eligible. We extracted data on the patients (age, sex, intensive care unit admission, comorbidities) and hospitals (public vs. private proprietary; for public hospitals, teaching, yes/no; and number of NSTI admissions, ≥ 3 NSTI cases/year, yes/no). Multivariable analyses were performed to identify independent predictors of 28-day mortality and in-hospital mortality using mixed logistic regression and Cox proportional hazards models, respectively.
RESULTS: We identified 1537 patients (915 males) with a median age of 60 years (interquartile range 48-75), admitted to 326 hospitals, public (82%) and admitting < 3 NSTI cases/year (93%). Overall, 364 patients died [23·7%; 95% confidence interval (CI) 21·6-25·9]. Patients treated in public teaching centres with ≥ 3 NSTI cases annually had lower 28-day mortality (adjusted odds ratio 0·68; 95% CI 0·46-0·99; P = 0·045) and in-hospital mortality rates than patients treated in local hospitals, even after adjusting for potentially relevant individual risk factors. No significant association was found between mortality and interhospital transfer.
CONCLUSIONS: Our findings highlight an increased survival in teaching centres with high-volume NSTI procedures. If confirmed in other settings, these findings reinforce the importance of expertise in early diagnosis and management of this condition.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28452064     DOI: 10.1111/bjd.15615

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  The roles of early surgery and comorbid conditions on outcomes of severe necrotizing soft-tissue infections.

Authors:  Rifat Latifi; Apar S Patel; David J Samson; Elizabeth H Tilley; Saranda Gashi; Roberto Bergamaschi; Ayman El-Menyar
Journal:  Eur J Trauma Emerg Surg       Date:  2018-05-22       Impact factor: 3.693

2.  Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.

Authors:  Dara L Horn; Emma A Roberts; Jolie Shen; Jeannie D Chan; Eileen M Bulger; Noel S Weiss; John B Lynch; Chloe Bryson-Cahn; Bryce R H Robinson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  Eight Tales of Cervical Necrotizing Fasciitis and Free Tissue Transfer.

Authors:  Nicholas A Rapoport; David S Lee; Jake J Lee; Sidharth V Puram; Ryan S Jackson; Patrik Pipkorn
Journal:  Ann Otol Rhinol Laryngol       Date:  2022-04-02       Impact factor: 1.973

4.  Non-necrotizing and necrotizing soft tissue infections in South America: A retrospective cohort study.

Authors:  Gustavo Lopes Gomes Siqueira; Ricardo Alves de Olinda; Camila Meira Barbosa de Siqueira; Analice Barros de Vasconcelos Sá Torres; Luana de Carvalho Viana Corrêa; Francisco de Assis Silva Lacerda; Pablo Luiz Fernandes Guimarães
Journal:  Ann Med Surg (Lond)       Date:  2020-09-11

5.  What Demographic and Clinical Factors Are Associated with In-hospital Mortality in Patients with Necrotizing Fasciitis?

Authors:  Jaret Karnuta; Joseph Featherall; Joshua Lawrenz; Jaymeson Gordon; Joshua Golubovsky; Jonah Thomas; Deepak Ramanathan; Claus Simpfendorfer; Lukas M Nystrom; Maja Babic; Nathan W Mesko
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

Review 6.  Interventions for necrotizing soft tissue infections in adults.

Authors:  Camille Hua; Romain Bosc; Emilie Sbidian; Nicolas De Prost; Carolyn Hughes; Patricia Jabre; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

7.  Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections.

Authors:  Dara L Horn; Jolie Shen; Emma Roberts; Theresa N Wang; Kevin S Li; Grant E O'Keefe; Joseph Cuschieri; Eileen M Bulger; Bryce R H Robinson
Journal:  J Trauma Acute Care Surg       Date:  2020-07       Impact factor: 3.697

8.  Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study.

Authors:  Tomas Urbina; Camille Hua; Emilie Sbidian; Romain Bosc; Françoise Tomberli; Raphael Lepeule; Jean-Winoc Decousser; Armand Mekontso Dessap; Olivier Chosidow; Nicolas de Prost
Journal:  Ann Intensive Care       Date:  2019-10-24       Impact factor: 6.925

9.  Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis.

Authors:  Femke Nawijn; Diederik P J Smeeing; Roderick M Houwert; Luke P H Leenen; Falco Hietbrink
Journal:  World J Emerg Surg       Date:  2020-01-08       Impact factor: 5.469

10.  Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort study.

Authors:  Morten Hedetoft; Martin Bruun Madsen; Lærke Bruun Madsen; Ole Hyldegaard
Journal:  BMJ Open       Date:  2020-10-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.